Mandatory notification of acquisition of shares by primary insider
Nykode Therapeutics ASA (NYKD) · publisert 18. mai 2022 kl. 16:00 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Martin Nicklasson | – | Kjøp | 10 000 | 32,05 NOK | 18. mai 2022 | NO0010714785 | MERK – Euronext Growth Oslo |
Vedlegg
- Attachment 220518.pdf (application/pdf, originaldokument)
Meldingstekst
Oslo, Norway, May 18, 2022 - Primary insider Martin Nicklasson, Chair of the Board of Nykode Therapeutics AS, has today acquired 10,000 shares in Nykode Therapeutics AS at a price of NOK 32.05 per share. Following the transaction, Martin Nicklasson holds 32,000 shares in Nykode Therapeutics AS.
Please see further details in the attached document.